NCT06394063View on ClinicalTrials.gov

Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients

NARecruitingINTERVENTIONAL

Enrollment

176

Participants

Timeline

Start Date

June 28, 2024

Primary Completion Date

June 30, 2027

Study Completion Date

June 30, 2027

Conditions

Systemic Lupus Erythematosus

Interventions

BIOLOGICAL

Telitacicept

Telitacicept 160 mg SC every other week

DRUG

Placebo

Placebo to Telitacicept

Trial Locations (1)

201112

RECRUITING

Ren Ji Hospital, Shanghai

All Listed Sponsors

lead

RenJi Hospital

OTHER